Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Obstructive Lung Diseases

  Free Subscription


06.06.2022

1 Allergy
2 Am J Respir Crit Care Med
5 Ann Allergy Asthma Immunol
14 Arch Bronconeumol
3 Eur Respir J
3 J Allergy Clin Immunol
3 J Asthma
1 N Engl J Med
2 Pediatr Allergy Immunol
1 Respir Res


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Allergy

  1. OOKA T, Raita Y, Fujiogi M, Freishtat RJ, et al
    Proteomics endotyping of infants with severe bronchiolitis and risk of childhood asthma.
    Allergy. 2022 May 27. doi: 10.1111/all.15390.
    PubMed         Abstract available


    Am J Respir Crit Care Med

  2. MIRAVITLLES M, Anzueto A
    Use of CT Lung Densitometry as Outcome Measure for Emphysema Progression: The Case of Losartan.
    Am J Respir Crit Care Med. 2022 Jun 2. doi: 10.1164/rccm.202205-0927.
    PubMed        

  3. WISE RA, Holbrook JT, Brown RH, Criner GJ, et al
    Clinical Trial of Losartan for Pulmonary Emphysema: Pulmonary Trials Cooperative LEEP Trial.
    Am J Respir Crit Care Med. 2022 Jun 1. doi: 10.1164/rccm.202201-0206.
    PubMed         Abstract available


    Ann Allergy Asthma Immunol

  4. SCIOSCIA BG, Lacedonia D, Quarato CMI, Tondo P, et al
    Could Transthoracic Ultrasound be useful to suggest a small airways disease in severe uncontrolled asthma?
    Ann Allergy Asthma Immunol. 2022 May 25. pii: S1081-1206(22)00491.
    PubMed         Abstract available

  5. CHUPP G, Wechsler ME
    Biologic Medications in Asthma: What have we learned from long-term studies?
    Ann Allergy Asthma Immunol. 2022 May 24. pii: S1081-1206(22)00489.
    PubMed        

  6. WANG EA, Goleva E, Ketosugbo K, Kern JA, et al
    Effect of immune checkpoint inhibitors on asthma.
    Ann Allergy Asthma Immunol. 2022 May 24. pii: S1081-1206(22)00487.
    PubMed        

  7. ZHANG H, Xian M, Shi X, Luo T, et al
    Blocking function of allergen-specific IgG, F(ab')2, and Fab antibodies prepared from patients undergoing Dermatophagoides pteronyssinus immunotherapy.
    Ann Allergy Asthma Immunol. 2022 Apr 8. pii: S1081-1206(22)00293.
    PubMed         Abstract available

  8. CHUNG Y, Katial R, Mu F, Cook EE, et al
    Real-world effectiveness of benralizumab: Results from the ZEPHYR 1 Study.
    Ann Allergy Asthma Immunol. 2022;128:669-676.
    PubMed         Abstract available


    Arch Bronconeumol

  9. GOLPE R, Figueira-Goncalves JM, Esteban C, Amado-Diago CA, et al
    Relationship Between the GesEPOC 2021 Classification of Risk Levels and Phenotypes and the Incidence of Adverse Events.
    Arch Bronconeumol. 2022;58:451-453.
    PubMed        

  10. DIAZ-PENA R, Julia RF, Montes JF, Silva RS, et al
    Polymorphisms in the FRMD4A Gene Are Associated With Chronic Obstructive Pulmonary Disease Susceptibility in a Latin American Population.
    Arch Bronconeumol. 2022;58:454-456.
    PubMed        

  11. HU-YANG C, Perez-Fernandez V, Andreu Rodriguez AL, Andujar Espinosa R, et al
    [Translated article] FEV1/FVC Cut-off Values for the Diagnosis of Airflow Obstruction in Pediatric Patients: The Pediatric Airflow Obstruction (PAO) Study.
    Arch Bronconeumol. 2022;58:T442-T443.
    PubMed        

  12. GONZALEZ-BARCALA FJ, Martinez-Torres AE, Mendez-Brea P, Garcia-Marcos L, et al
    With the Torch in the Mist of the United Airway Disease: Atopic March and Other Arguments in the Search for Evidence.
    Arch Bronconeumol. 2022;58:386-387.
    PubMed        

  13. FOSCHINI G, Rodriguez CM, Rubio MM, Baldo X, et al
    Placental Transmogrification of the Lung.
    Arch Bronconeumol. 2022;58:433.
    PubMed        

  14. HU-YANG C, Perez-Fernandez V, Andreu Rodriguez AL, Andujar Espinosa R, et al
    FEV1/FVC Cut-off Values for the Diagnosis of Airflow Obstruction in Pediatric Patients: The Pediatric Airflow Obstruction (PAO) Study.
    Arch Bronconeumol. 2022;58:442-443.
    PubMed        

  15. DIAZ-PENA R, Julia RF, Montes JF, Silva RS, et al
    [Translated article] Polymorphisms in the FRMD4A Gene Are Associated With Chronic Obstructive Pulmonary Disease Susceptibility in a Latin American Population.
    Arch Bronconeumol. 2022;58:T454-T456.
    PubMed        

  16. GONZALEZ-BARCALA FJ, Martinez-Torres AE, Mendez-Brea P, Garcia-Marcos L, et al
    [Translated article] With the Torch in the Mist of the United Airway Disease: Atopic March and Other Arguments in the Search for Evidence.
    Arch Bronconeumol. 2022;58:T386-T387.
    PubMed        

  17. PEREZ PEREZ JL, Garcia-Manso IG, Garcia Sevila R
    [Translated article] Acute Fibrinous and Organizing Pneumonia Associated With Immunotherapy (Pembrolizumab).
    Arch Bronconeumol. 2022;58:T425-T426.
    PubMed        

  18. RODRIGUEZ C, Solier A, Marin M, Tenes A, et al
    [Translated article] Prognostic Significance of Findings on CTPA Supporting an Alternative Diagnosis to PE Among Patients Hospitalized for an Exacerbation of COPD: Predefined Subanalysis of the SLICE Trial.
    Arch Bronconeumol. 2022;58:T412-T417.
    PubMed         Abstract available

  19. FOSCHINI G, Rodriguez CM, Rubio MM, Baldo X, et al
    [Translated article] Placental Transmogrification of the Lung.
    Arch Bronconeumol. 2022;58:T433.
    PubMed        

  20. RODRIGUEZ C, Solier A, Marin M, Tenes A, et al
    Prognostic Significance of Findings on CTPA Supporting an Alternative Diagnosis to PE Among Patients Hospitalized for an Exacerbation of COPD: Predefined Subanalysis of the SLICE Trial.
    Arch Bronconeumol. 2022;58:412-417.
    PubMed         Abstract available

  21. GOLPE R, Figueira-Goncalves JM, Esteban C, Amado-Diago CA, et al
    [Translated article] Relationship Between the GesEPOC 2021 Classification of Risk Levels and Phenotypes and the Incidence of Adverse Events.
    Arch Bronconeumol. 2022;58:T451-T453.
    PubMed        

  22. NAVAS-BUENO B, Casas-Maldonado F, Padilla-Galo A, Gonzalez-Moya-Mondelo E, et al
    High Adherence, Microbiological Control and Reduced Exacerbations in Patients With Non-Cystic Fibrosis Bronchiectasis Treated With Nebulised Colistin. A Prospective Observational Study.
    Arch Bronconeumol. 2022 Apr 27. pii: S0300-2896(22)00320.
    PubMed        


    Eur Respir J

  23. FAIZ A, van den Berge M
    Quality over quantity: the importance of collecting relevant samples to understand complex diseases.
    Eur Respir J. 2022;59.
    PubMed        

  24. HIGHAM A, Beech A, Jackson N, Lea S, et al
    Sputum cell counts in COPD patients who use electronic cigarettes.
    Eur Respir J. 2022;59.
    PubMed        

  25. XU F, Vasilescu DM, Kinose D, Tanabe N, et al
    The molecular and cellular mechanisms associated with the destruction of terminal bronchioles in COPD.
    Eur Respir J. 2022;59.
    PubMed         Abstract available


    J Allergy Clin Immunol

  26. BELLANTI JA
    Seasonal-specific Variations of the Upper Airway Microbiome and Childhood Asthma: Friend or Foe?
    J Allergy Clin Immunol. 2022 May 24. pii: S0091-6749(22)00707.
    PubMed        

  27. TU X, Kim RY, Brown AC, De Jong E, et al
    Airway and parenchymal transcriptomics in a novel model of asthma and COPD overlap.
    J Allergy Clin Immunol. 2022 May 25. pii: S0091-6749(22)00706.
    PubMed         Abstract available

  28. THOMPSON D, Wood LG, Williams EJ, McLoughlin RF, et al
    Endotyping pediatric obesity-related asthma: contribution of anthropometrics, metabolism, nutrients, and CD4+ lymphocytes, to pulmonary function.
    J Allergy Clin Immunol. 2022 May 30. pii: S0091-6749(22)00753.
    PubMed         Abstract available


    J Asthma

  29. BOZEK A, Zalejska Fiolka J, Czuba Z, Miodonska M, et al
    Allergy to Der p 23 influences the cytokine profile in patients with allergic asthma - a preliminary study.
    J Asthma. 2022 May 28:1-5. doi: 10.1080/02770903.2022.2083635.
    PubMed         Abstract available

  30. PANESAR R, Grossman J, Nachman S
    Antibiotic use among admitted pediatric patients in the United States with status asthmaticus before and during the COVID-19 pandemic.
    J Asthma. 2022 May 28:1-11. doi: 10.1080/02770903.2022.2083636.
    PubMed         Abstract available

  31. ORTEGA H, Bharmal N, Khatri S
    Primary Care Referral Patterns for Patients with Asthma: Analysis of real-world data.
    J Asthma. 2022 May 27:1-9. doi: 10.1080/02770903.2022.2082308.
    PubMed         Abstract available


    N Engl J Med

  32. SCHATZ M
    Another Rescue Therapy Option for Patients with Moderate-to-Severe Asthma.
    N Engl J Med. 2022;386:2139-2140.
    PubMed        


    Pediatr Allergy Immunol

  33. CHANG YH, Yeh KW, Huang JL, Su KW, et al
    Metabolomics analysis reveals molecular linkages for the impact of vitamin D on childhood allergic airway diseases.
    Pediatr Allergy Immunol. 2022;33:e13785.
    PubMed         Abstract available

  34. HAAHTELA T
    Biodiversity for resilience-What is needed for allergic children.
    Pediatr Allergy Immunol. 2022;33:e13779.
    PubMed         Abstract available


    Respir Res

  35. LEE H, Kovacs C, Mattman A, Hollander Z, et al
    The impact of IgG subclass deficiency on the risk of mortality in hospitalized patients with COPD.
    Respir Res. 2022;23:141.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: